secwatch.observer — SEC 8-K summary
======================================

Issuer:     Medtronic plc (MDT)
CIK:        0001613103
Form:       8-K
Filed at:   2022-05-26T23:59:59+00:00
Accession:  0001613103-22-000016
Event type: other_material
Sentiment:  neutral
Materiality: 0.90
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Medtronic posts FY22 rev +5%, Q4 adj EPS +2%; hikes dividend 8%, forms kidney JV with DaVita
--------------------------------------------------------------------------------

- FY22 revenue $31.686B, +5% reported and organic; Q4 revenue $8.1B, -1% reported, +1% organic.
- Q4 GAAP diluted EPS $1.10 (+10%), non-GAAP diluted EPS $1.52 (+2%); FY22 GAAP diluted EPS $3.73 (+40%).
- Quarterly dividend raised to $0.68 from $0.63 (+8%); annual $2.72; 45th consecutive year of increases.
- Medtronic and DaVita form equally-owned kidney device JV; Medtronic contributes RCS ($325M FY22 rev). DaVita pays up to $400M value. Close expected calendar 2023.
- FY23 guidance issued; no material adjusted EPS impact from JV in current or near-term fiscal years.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1613103/000161310322000016/0001613103-22-000016-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1613103/000161310322000016/mdt-20220526.htm
  HTML page:      https://secwatch.observer/filing/0001613103-22-000016

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer